622 filings
Page 18 of 32
8-K
NBSE
NeuBase Therapeutics Inc
15 Dec 16
Ohr Pharmaceutical Announces Closing of Public Offering of Common Stock and Warrants
12:00am
NT 10-K
NBSE
NeuBase Therapeutics Inc
14 Dec 16
Notice of late annual filing
12:00am
424B5
NBSE
NeuBase Therapeutics Inc
9 Dec 16
Prospectus supplement for primary offering
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
8 Dec 16
Ohr Pharmaceutical Announces Proposed Public Offering of Common Stock and Warrants
12:00am
424B5
NBSE
NeuBase Therapeutics Inc
7 Dec 16
Prospectus supplement for primary offering
12:00am
10-K/A
2015 FY
NBSE
NeuBase Therapeutics Inc
Annual report (amended)
7 Dec 16
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
12 Aug 16
Ohr Pharmaceutical Reports Third Quarter 2016 Financial and Business Results
12:00am
10-Q
2016 Q3
NBSE
NeuBase Therapeutics Inc
Quarterly report
9 Aug 16
12:00am
4
NBSE
NeuBase Therapeutics Inc
2 Aug 16
Ohr Pharmaceutical / Jason Scott Slakter ownership change
12:00am
SC 13D/A
NBSE
NeuBase Therapeutics Inc
2 Aug 16
Ohr Pharmaceutical Inc
12:00am
4
Backenroth Samuel
21 Jun 16
Ohr Pharmaceutical / Samuel Backenroth ownership change
12:00am
4
NBSE
NeuBase Therapeutics Inc
21 Jun 16
Ohr Pharmaceutical / Jason Scott Slakter ownership change
12:00am
4
NBSE
NeuBase Therapeutics Inc
26 May 16
Ohr Pharmaceutical / Jason Scott Slakter ownership change
12:00am
4
NBSE
NeuBase Therapeutics Inc
25 May 16
Ohr Pharmaceutical / Jason Scott Slakter ownership change
12:00am
4
Backenroth Samuel
24 May 16
Ohr Pharmaceutical / Samuel Backenroth ownership change
12:00am
10-Q
2016 Q2
NBSE
NeuBase Therapeutics Inc
Quarterly report
10 May 16
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
10 May 16
Ohr Pharmaceutical Reports Second Quarter 2016 Financial and Business Results
12:00am
4
NBSE
NeuBase Therapeutics Inc
12 Apr 16
Ohr Pharmaceutical / Jason Scott Slakter ownership change
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
29 Mar 16
Ohr Pharmaceutical, Inc. Announces SPA Agreement with US FDA and Initiation of Phase III Wet AMD Clinical Program
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
21 Mar 16
Departure of Directors or Certain Officers
12:00am